Related Experiment Video
Updated: Jan 9, 2026

A Mass Spectrometry-Based Approach to Identify Phosphoprotein Phosphatases and their Interactors
Published on: April 29, 2022
Integrative phosphoproteomic network analysis identifies CAMK2D as a shared regulator of TPD52 family proteins in
Noreen A Khan1, Amal Fahma1, Althaf Mahin1
1Centre for Integrative Omics Data Science, Yenepoya (Deemed to be University), Mangalore, 575018, Karnataka, India.
Abstract:
The Tumour Protein D52 (TPD52) family, including TPD52, TPD52L1, and TPD52L2, plays critical roles in membrane trafficking, lipid metabolism, and oncogenic signalling, with its overexpression linked to multiple cancers. Phosphorylation is a key regulator of their functions, yet their phosphoproteomic landscape remains underexplored. This study integrates over 3,825 public human phosphoproteomic datasets to map phosphorylation profiles of TPD52, TPD52L1, and TPD52L2, identifying dominant phosphosites like S171, S176, S149, and S12, S166 within conserved coiled-coil and PEST-like domains. CAMK2D was identified as a predominant shared kinase, alongside CDK2 and GRK5, associating these modifications with calcium signaling, cell cycle progression, and cytoskeletal remodeling. Co-phosphoregulation highlighted positive interactions with ABRAXAS2 and negative correlations with ABLIM3, implicating involvement in ubiquitin-mediated degradation, epithelial-mesenchymal transition (EMT), and cytokinesis. Notably, hypophosphorylation at TPD52_S171/S176 was observed in hepatocellular and lung carcinomas, whereas hyperphosphorylation at TPD52L2_S166 prevailed in ovarian and pancreatic cancers, underscoring biomarker utility. Phosphorylation-driven interactomes emphasized roles in vesicular trafficking and oncogenesis This study catalogues the phosphorylation events and explores the potential of TPD52 family as a phosphoregulated hub in cancer biology, with CAMK2D as a potential therapeutic target.
Insights
This study maps phosphorylation sites on the Tumour Protein D52 (TPD52) family, revealing kinase interactions and altered phosphorylation patterns in various cancers. These findings highlight TPD52 family proteins as potential cancer biomarkers and therapeutic targets.
Area of Science:
- Molecular Biology
- Cancer Research
- Proteomics
Background:
- The Tumour Protein D52 (TPD52) family (TPD52, TPD52L1, TPD52L2) is implicated in membrane trafficking, lipid metabolism, and cancer signaling.
- Overexpression of TPD52 family members is linked to various cancers.
- The role of phosphorylation in TPD52 family function is not well understood, despite its importance as a regulatory mechanism.
Purpose of the Study:
- To comprehensively map the phosphoproteomic landscape of the TPD52 family.
- To identify key kinases and interacting proteins involved in TPD52 family phosphorylation.
- To investigate the potential of TPD52 family phosphorylation patterns as cancer biomarkers.
Main Methods:
- Integration of over 3,825 public human phosphoproteomic datasets.
- Identification and analysis of dominant phosphosites within conserved domains.
- Kinase-substrate prediction and co-phosphoregulation network analysis.
Main Results:
- Dominant phosphosites (e.g., S171, S176, S149, S12, S166) were identified in TPD52, TPD52L1, and TPD52L2.
- CAMK2D, CDK2, and GRK5 were identified as predominant kinases, linking phosphorylation to calcium signaling, cell cycle, and cytoskeleton.
- Altered phosphorylation patterns (hypo- and hyperphosphorylation) were observed in specific cancer types (e.g., hepatocellular, lung, ovarian, pancreatic cancers).
Conclusions:
- This study provides a detailed catalogue of TPD52 family phosphorylation events.
- TPD52 family proteins function as a phosphoregulated hub in cancer biology, influencing processes like EMT and cytokinesis.
- Specific phosphorylation sites and kinases, such as CAMK2D, represent potential diagnostic biomarkers and therapeutic targets in cancer.
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
cAMP-dependent Protein Kinase Pathways
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...

